Cyclobenzaprine has possible interactions with alcohol, some other drugs, and certain supplements. Examples include opioids and certain antidepressants. Talk with your doctor to avoid potentially ...
Commercially launched in the U.S. in November 2025, TONMYA (cyclobenzaprine HCl sublingual tablets) for long-term daily dosing at bedtime is the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results